Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact. (Q40874319)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430518%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

review article

1 reference

title

Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430518%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Antiviral Agents: Characteristic Activity Spectrum Depending on the Molecular Target With Which They Interact (English)

0 references

Erik De Clercq

1

0 references

author name string

De Clercq E

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430518%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430518%20AND%20SRC:MED&resulttype=core&format=json

Advances in Virus Research

12 October 2019

1993

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430518%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430518%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

1-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430518%20AND%20SRC:MED&resulttype=core&format=json

Antiherpes virus activity and effect on deoxyribonucleoside triphosphate pools of (E)-5-(2-bromovinyl)-2'-deoxycytidine in combination with deaminase inhibitors

12 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2'-deoxyuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Metabolic fate of (E)-5-(2-bromovinyl)-2'-deoxyuridine in herpes simplex virus- and mock-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

In vitro activity of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against newly isolated clinical varicella-zoster virus strains

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2'-nor-cyclic GMP on adenovirus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Highly potent and selective inhibition of HIV-1 replication by 6-phenylthiouracil derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Activity of dextran sulfate and other polyanionic polysaccharides against human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Anti-retrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in vivo increases when it is less frequently administered

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2′,3′-dideoxyinosine on human immunodeficiency virus in peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

9-(2-Phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

An analysis of the inhibition of replication of HIV and MuLV by some 3'-blocked pyrimidine analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Phosphorylation of the carbocyclic analog of 2'-deoxyguanosine in cells infected with herpes viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Antiviral activity of C-5 substituted tubercidin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of HIV and virus replication by polysulphated polyxylan: HOE/BAY 946, a new antiviral compound.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Metabolism of the carbocyclic nucleoside analogue carbovir, an inhibitor of human immunodeficiency virus, in human lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 11. Molecular dissections of neplanocin A as potential inhibitors of S-adenosylhomocysteine hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and antiviral activity of the nucleotide analogue (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Mechanism and Specificity of Action of Ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Activities of (-)-carbovir and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and structure-activity relationships of 6-substituted 2',3'-dideoxypurine nucleosides as potential anti-human immunodeficiency virus agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Correlation between the antiviral activity of acyclic and carbocyclic adenosine analogues in murine L929 cells and their inhibitory effect on L929 cells S-adenosylhomocysteine hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Influence of S-adenosylhomocysteine hydrolase inhibitors on S-adenosylhomocysteine and S-adenosylmethionine pool levels in L929 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and anti-HIV activities of low molecular weight aurintricarboxylic acid fragments and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Specific HIV-1 reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Selective antiherpes agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Biochemical aspects of the selective antiherpes activity of nucleoside analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Antiviral and antimetabolic activities of neplanocins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

S-adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Recent Advances in the Search for Selective Antiviral Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

New acquisitions in the development of anti-HIV agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Antiviral Activity Spectrum of Nucleoside and Nucleotide Analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Broad-spectrum anti-DNA virus and anti-retrovirus activity of phosphonylmethoxyalkylpurines and -pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Antiviral potency of adenosine analogues: correlation with inhibition of S-adenosylhomocysteine hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Alkyl esters of 3-adenin-9-yl-2-hydroxypropanoic acid: a new class of broad-spectrum antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Fluoroimidazoles as antiviral agents and inhibitors of polynucleotide biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

(S)-9-(2,3-Dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Selective antiherpetic activity of carbocyclic analogues of (E)-5-(2-halogenovinyl)-2′-deoxyuridines: Dependence on specific phosphorylation by viral thymidine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

A novel selective broad-spectrum anti-DNA virus agent

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5'-nor derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Anti-Hiv-1 Activity of 2',3'-Dideoxinucleoside Analogues : Structure-Activity Relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Phosphorylation of 3'-azido-2',3'-dideoxyuridine and preferential inhibition of human and simian immunodeficiency virus reverse transcriptases by its 5'-triphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Molecular analysis of the inhibitory effect of phosphorylated ribavirin on the vesicular stomatitis virus in vitro polymerase reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

N-carboxymethylchitosan-N,O-sulfate as an anti-HIV-1 agent

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Phosphonylmethoxyalkylpurines and -pyrimidines as inhibitors of African swine fever virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

The broad spectrum antiviral agent ribavirin inhibits capping of mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Biochemistry and biological effects of the pyrazofurins (pyrazomycins): initial clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of infection with human immunodeficiency virus type 1 by sulfated gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and antiviral activity of 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]purines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

9-(trans-2',trans-3'-Dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine: analogs of neplanocin A which retain potent antiviral activity but exhibit reduced cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Relationship between intracellular concentration of S-adenosylhomocysteine and inhibition of vaccinia virus replication and inhibition of murine L-929 cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of human immunodeficiency virus 1 reverse transcriptase by 3'-azidothymidine triphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Cellular pharmacology of 2',3'-dideoxy-2',3'-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

In vitro activity of mannan sulfate, a novel sulfated polysaccharide, against human immunodeficiency virus type 1 and other enveloped viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

In vitro anti-HIV-1 activity of chondroitin polysulphate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of HIV-1 infectivity with curdlan sulfate in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Mechanism of HIV reverse transcriptase: enzyme-primer interaction as revealed through studies of a dNTP analogue, 3'-azido-dTTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Potential anti-AIDS drugs. 2',3'-Dideoxycytidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Azidothymidine triphosphate is an inhibitor of both human immunodeficiency virus type 1 reverse transcriptase and DNA polymerase gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Treatment of latent rabbit and human papillomavirus infections with 9-(2-phosphonylmethoxy)ethylguanine (PMEG)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin- 2(1H)-one (TIBO) derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-on e (TIBO) derivatives. 2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Antiviral activity of 2',3'-dideoxycytidin-2'-ene (2',3'-dideoxy-2',3'-didehydrocytidine) against human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and antiviral activity of various 3'-azido analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1, HTLV-III/LAV).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibitory effects of antiherpesviral thymidine analogs against varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and antiviral evaluation of 6'-substituted aristeromycins: potential mechanism-based inhibitors of S-adenosylhomocysteine hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and antiviral activity of monofluoro and difluoro analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

The design, synthesis and antileukemic activity of 5-alkynyl-1-beta-D-ribofuranosylimidazole-4-carboxamides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Potent inhibition of hepatitis B virus production in vitro by modified pyrimidine nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Identification of small DNA fragments synthesized in herpes simplex virus-infected cells in the presence of acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of herpes simplex virus DNA polymerase by diphosphates of acyclic phosphonylmethoxyalkyl nucleotide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Nucleosides and nucleotides. 96. Synthesis and antitumor activity of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Carbocyclic analogue of 3-deazaadenosine: a novel antiviral agent using S-adenosylhomocysteine hydrolase as a pharmacological target

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Anti-HIV activity of dextran sulphate as determined under different experimental conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl) derivatives of adenine and 3-deazaadenine: potent inhibitors of bovine liver S-adenosylhomocysteine hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Computer-assisted structure-activity correlations of dideoxynucleoside analogs as potential anti-HIV drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Selective inhibition of human cytomegalovirus replication by a novel nucleoside, oxetanocin G.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Antiviral effects of phosphonoformate (PFA, foscarnet sodium)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Induction of Endogenous Virus and of Thymidine Kinase by Bromodeoxyuridine in Cell Cultures Transformed by Friend Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Cellular uptake of phosphonylmethoxyalkylpurine derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

In vitro and in vivo evidence that the antiviral activity of 2',3'-dideoxycytidine is target cell dependent in a feline retrovirus animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Antiviral action and selectivity of 6-azauridine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Metabolism and action of neplanocin A in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Mutations that confer resistance to mycophenolic acid and ribavirin on sindbis virus map to the nonstructural protein nsP1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Syncytium formation and destruction of bystander CD4+ cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Flow cytometric method to monitor the destruction of CD4+ cells following their fusion with HIV-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of influenza RNA synthesis by virazole (ribavirin)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Resolution of racemic carbocyclic analogues of purine nucleosides through the action of adenosine deaminase. Antiviral activity of the carbocyclic 2'-deoxyguanosine enantiomers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of infectivity of human immunodeficiency virus by a novel nucleoside, oxetanocin, and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Evaluation of carbodine, the carbocyclic analog of cytidine, and related carbocyclic analogs of pyrimidine nucleosides for antiviral activity against human influenza Type A viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Activity of selenazofurin against influenza A and B viruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Incorporation into nucleic acids of the antiherpes guanosine analog buciclovir, and effects on DNA and protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and anti-HIV activity of several 2'-fluoro-containing pyrimidine nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Antiviral effects of 3'-azido-3'-deoxythymidine, 2',3'-dideoxycytidine, and 2',3'-dideoxyadenosine against simian acquired immunodeficiency syndrome-associated type D retrovirus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

A ring-enlarged oxetanocin A analogue as an inhibitor of HIV infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Dextran sulphate, a potent anti-HIV agent in vitro having synergism with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and antiviral activity evaluation of 3'-fluoro-3'-deoxyribonucleosides: broad-spectrum antiviral activity of 3'-fluoro-3'-deoxyadenosine.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Potent and selective activity of a new carbocyclic nucleoside analog (carbovir: NSC 614846) against human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Properties of a 9-(2-phosphonylmethoxyethyl)adenine (PMEA)-resistant herpes simplex virus type 1 virus mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

2-Methylpropyl ester of 3-(adenin-9-yl)-2-hydroxypropanoic acid. Mechanism of antiviral action in vaccinia virus-infected L929 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Effects of 2?,3?-dideoxynucleosides on mammalian cells and viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and anti-HIV-1 activity of 2'-"up"-fluoro analogs of active anti-AIDS nucleosides 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxycytidine (DDC)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Sulphoevernan, a polyanionic polysaccharide, and the narcissus lectin potently inhibit human immunodeficiency virus infection by binding to viral envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Synthesis and antiviral activity of 5-heteroaryl-substituted 2'-deoxyuridines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Sulfation of the immunomodulating polysaccharide lentinan: A novel strategy for antivirals to human immunodeficiency virus (HIV)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2808%2960082-2

7 January 2021

10.1016/S0065-3527(08)60082-2

Identifiers

DOI

0 references

1 reference